Departmental Publications


Publications Spotlighted

Payer LM, Steranka JP, Ardeljan D, Walker J, Fitzgerald KC, Calabresi PA, Cooper TA, Burns KH. Alu insertion variants alter mRNA splicing. Nucleic Acids Res 2019 Jan 10;47(1):421-31.

Rodriguez FJ, Brosnan-Cashman JA, Allen SJ, Vizcaino MA, Giannini C, Camelo-Piragua S, Webb M, Matsushita M, Wadhwani N, Tabbarah A, Hamideh D, Jiang L, Chen L, Arvanitis LD, Alnajar HH, Barber JR, Rodriguez-Velasco A, Orr B, Heaphy CM. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia. Brain Pathol 2019 Jan;29(1):126-40. 6.6

Tamma PD, Fan Y, Bergman Y, Pertea G, Kazmi AQ, Lewis S, Carroll KC, Schatz MC, Timp W, Simner PJ. Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates. Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01923-18. doi: 10.1128/AAC.01923-18. Print 2019 Jan.

Wang Y, Xu J, Chang L, Meyers CA, Zhang L, Broderick K, Lee M, Peault B, James AW. Relative contributions of adipose-resident CD146+ pericytes and CD34+ adventitial progenitor cells in bone tissue engineering. NPJ Regen Med. 2019 Jan 7;4:1. doi: 10.1038/s41536-018-0063-2. eCollection 2019.

2018 Publications

AUTOPSY

  1. Hooper JE, Richardson H, Maters AW, Carroll KC, Pronovost PJ. The Association of Departmental Quality Infrastructure and Positive Change: A Pathology Department Illustration. Acad Pathol 2018 Jan 18;5: 2374289517744753. eCollection.

CARDIOVASCULAR PATHOLOGY

  1. Bishop E, Brown EE, Fajardo J, Barouch LA, Judge DP, Halushka MK. Seven factors predict a delayed diagnosis of cardiac amyloidosis. Amyloid. 2018 Sep;25(3):174-9.
  2. Halushka MK, Fromm B, Peterson KJ, McCall MN. Big Strides in Cellular MicroRNA Expression. Trends Genet. 2018 Mar;34(3):165-7.
  3. Jaquenod De Giusti C, Roman B, Das S. The Influence of MicroRNAs on Mitochondrial Calcium. Front Physiol. 2018 Sep 21;9:1291. eCollection 2018.
  4. Lu Y, Baras AS, Halushka MK. miRge 2.0 for comprehensive analysis of microRNA sequencing data. BMC Bioinformatics. 2018 Jul 23;19(1):275.
  5. Macgregor-Das AM, Das S. A microRNA's journey to the center of the mitochondria. Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H206-15.
  6. Yano T, Abe K, Tanno M, Miki T, Kuno A, Miura T, Steenbergen C. Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury? J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):350-7.
  7. Wang TY, Lee D, Fox-Talbot K, Arking DE, Chakravarti A, Halushka MK. Cardiomyocytes have mosaic patterns of protein expression. Cardiovasc Pathol 2018 May-June;34:50-7.

CLINICAL CHEMISTRY

  1. Bakshi RP, Breakey J, Manohar M, Jois B, Fuchs EJ, Marzinke MA. Short Communication: Specimen Processing Impacts Tissue Tenofovir Pharmacokinetic Measurements. AIDS Res Hum Retroviruses. 2018 Apr;34(4):354-6.
  2. Clark DJ, Hu Y, Bocik W, Chen L, Schnaubelt M, Roberts R, Shah P, Whiteley G, Zhang H. Evaluation of NCI-7 Cell Line Panel as a Reference Material for Clinical Proteomics. J Proteome Res 2018 Jun;17(6):2205-15.
  3. Höti N, Yang S, Hu Y, Shah P, Haffner MC, Zhang H. Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells. Prostate Cancer Prostatic Dis. 2018 Apr;21(1):137-46.
  4. Hu Y, Shah P, Clark DJ, Ao M, Zhang H. Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides. Anal Chem 2018 Jul 3;90(13):8065-71.
  5. Hummert P, Parsons TL, Ensign LM, Hoang T, Marzinke MA. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs. J Pharm Biomed Anal 2018 Apr;152:248-56.
  6. Sokoll LJ, Mangold L, Mohr P, Dua R, Partin AW. High "phi"ve. J Appl Lab Med 2018 Sep 3:333-5. (Letter).
  7. Sun S, Hu Y, Jia L, Toghi Eshghi S, Liu Y, Shah P, Zhang H. Site-specific Profiling of Serum Glycoproteins Using N-linked Glycan and Glycosite Analysis Reveals Atypical N-Glycosylation Sites on Albumin and Alpha-1B-glycoprotein. Anal Chem. 2018 May 15;90(10):6292-9.
  8. Yang W, Ao M, Hu Y, Li QK, Zhang H. Mapping the O-glycoproteome using site-specific extraction of O-linked glycopeptides (EXoO). Mol Syst Biol 2018 Nov 20;14(11):e8486.
  9. Yang G, Hu Y, Sun S, Ouyang C, Yang W, Wang Q, Betenbaugh M, Zhang H. Comprehensive Glycoproteomic Analysis of Chinese Hamster Ovary Cells. Anal. Chem 2018 Nov;90(24):14294-302.

CYTOPATHOLOGY

  1. Alexander C, Maleki Z. Ameloblastic carcinoma with metastasis to the parotid gland. Diagn Cytopathol 2018 Feb;46(2):162-4.
  2. Allison DB, Sharma R, Cowan ML, VandenBussche CJ. Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens. Acta Cytol 2018 July-Aug;62(4):302-10.
  3. Allison DB, Simner PJ, Ali SZ. Identification of infectious organisms in cytopathology: A review of ancillary diagnostic techniques. Cancer Cytopathol. 2018 Aug;126 Suppl 8:643-53.
  4. Allison DB, VandenBussche CJ, Rooper LM, Wakely PE Jr, Rossi ED, Faquin WC, Ali SZ. Nodular fasciitis of the parotid gland: A challenging diagnosis on FNA. Cancer Cytopathol 2018 Oct;126(10):872-80.
  5. Cowan ML, VandenBussche CJ. The Paris System for Reporting Urinary Cytology: early review of the literature reveals successes and rare shortcomings. J Am Soc of Cytopathol. 2018 Jul-Aug;7(4):185-94.
  6. Fite JJ, Ali SZ, VandenBussche CJ. Fine-needle aspiration of a pancreatic neuroendocrine tumor with prominent rhabdoid features. Diagn Cytopathol 2018 Jul;46(7):600-3.
  7. Fite JJ, Maleki Z. Paraganglioma: Cytomorphologic features, radiologic and clinical findings in 12 cases. Diagn Cytopathol. 2018 Jun;46(6):473-81.
  8. Fite JJ, Rosenthal DL, VandenBussche CJ. When words matter: A "suspicious" urinary tract cytology diagnosis improves patient follow-up among nonurologists. Cancer Cytopathol 2018 Apr;126(4):282-8.
  9. Hutchings D, Maleki Z, Rodriguez EF. Pulmonary non-small cell carcinoma with morphologic features of adenocarcinoma or "non-small cell carcinoma favor adenocarcinoma" in cytologic specimens share similar clinical and molecular genetic characteristics. Am J Clin Pathol 2018 Apr;149(6):514-21.
  10. Illei PB, Wong W, Wu N, Chu L, Gupta R, Schulze K, Gubens MA. ALK Testing Trends and Patterns Among Community Practices in the United States. DOI: 10.1200/PO.18.00159 JCO Precision Oncology - published online October 3, 2018.
  11. Lilo MT, Bishop JA, Olson MT, Ali SZ. Adamantinoma-like Ewing sarcoma of the parotid gland: Cytopathologic findings and differential diagnosis. Diagn Cytopathol. 2018 Mar;46(3):263-6.
  12. Maleki Z, Miller JA, Arab SE, Fadda G, Bo P, Wise O, Rossi ED, Jhala N, Ashish C, Ali SZ, Wang H. "Suspicious" salivary gland FNA: Risk of malignancy and interinstitutional variability. Cancer Cytopathol. 2018 Feb;126(2):94-100.
  13. McClain A, Sakowski L, Conti M, Zhang H, Li QK. Intranuclear inclusion in conventional clear cell renal cell carcinoma (ccRCC): Diagnosis and differential diagnosis. Arch Urol Res. 2018;2(1):5-7.
  14. Osmani L, Askin F, Gabrielson E, Li QK. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2018 Oct;52(Pt 1):103-9.
  15. Rodriguez EF, Chowsilpa S, Maleki Z. Insulinoma-Associated Protein 1 Immunostain: A Diagnostic Tool for Pulmonary Small Cell Carcinoma in Cytology. Acta Cytol 2018 Sept;62(5-6):333-8.
  16. Rodriguez EF, Chowsilpa S, Maleki Z. The Differential Diagnosis in Nonlymphoproliferative Malignant Pleural Effusion Cytopathology and Its Correlation with Patients' Demographics. Acta Cytol. 2018;62(5-6):436-42.
  17. Rodriguez EF, VandenBussche CJ, Chowsilpa S, Maleki Z Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis. Cancer Cytopathol. 2018 Oct;126(10):853-9.
  18. Salehi S, Maleki Z. Diagnostic challenges and problem cases in salivary gland cytology: A 20-year experience. Cancer Cytopathol. 2018 Feb;126(2):101-11.
  19. Salimian KJ, Fazeli R, Zheng G, Ettinger D, Maleki Z. V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics. Acta Cytol 2018 Mar-Apr;62(2):79-84.
  20. VandenBussche CJ, Allison DB, Gupta M, Ali SZ, Rosenthal DL. A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns. Cancer Cytopathol. 2018 Jun;126(6):381-9.
  21. Zhou AG, Levinson KL, Rosenthal DL, VandenBussche CJ. Performance of Ovarian Cyst Fluid Fine Needle Aspiration Cytology. Cancer Cytopathol. 2018 Feb;126(2):112-1.

GI/LIVER PATHOLOGY

  1. Adler BL, Pezhouh MK, Kim A, Luan L, Zhu Q, Gani F, Yarchoan M, Chen J, Voltaggio L, Parian A, Lazarev M, Lauwers GY, Pawlik TM, Montgomery EA, Jaffee E, Le DT, Taube JM, Anders RA. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med. 2018 Jun;283(6):568-77.
  2. Byrnes K, Oshima K. Liver transplantation pathology: a timeline based approach and review. Diagnostic Histopathology 2018 Dec: 24 (12):508-13.
  3. Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel I, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins MG. Risk of Neoplastic Progression in High-Risk Individuals Undergoing Long-Term Surveillance for Pancreatic Cancer. Gastroenterology. 2018 Sep;155(3):740-51.
  4. Canto MI, Montgomery E. Wide-area transepithelial sampling with 3-dimensional cytology: Does it detect more dysplasia or yield more hype? Gastrointest Endosc. 2018 Feb;87(2):356-39. (Editorial).
  5. Chianchiano P, Pezhouh MK, Kim A, Luchini C, Cameron A, Weiss MJ, He J, Voltaggio L, Oshima K, Anders RA, Wood LD. Distinction of Intrahepatic Metastasis from Multicentric Carcinogenesis in Multifocal Hepatocellular Carcinoma Using Molecular Alterations. Hum Pathol. 2018 Feb; 72:127-34.
  6. Felsenstein M, Hruban RH, Wood LD. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis. Adv Anat Pathol. 2018 Mar;25(2):131-42.
  7. Felsenstein M, Noë M, Masica DL, Hosoda W, Chianchiano P, Fischer CG, Lionheart G, Brosens LAA, Pea A, Yu J, Gemenetzis G, Groot VP, Makary MA, He J, Weiss MJ, Cameron JL, Wolfgang CL, Hruban RH, Roberts NJ, Karchin R, Goggins MG, Wood LD. IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut 2018 Sep;67(9):1652-62.
  8. Hata T, Dal Molin M, McGregor-Das A, Song TJ, Wolfgang C, Eshleman JR, Hruban RH, Goggins M. Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. J Mol Diagn. 2018 Jan;20(1):46-55.
  9. Hata T, Suenaga M, Marchionni L, Macgregor-Das A, Yu J, Shindo K, Tamura K, Hruban RH, Goggins M. Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol 2018 Jul;188(7):1723-33.
  10. Hutchings D, Wood LD, Hruban RH. Cancerization of the pancreatic ducts: demonstration of a common and under-recognized process using immunolabeling of paired duct lesions and invasive pancreatic ductal adenocarcinoma for p3 and Smad4 expression. Am J Surg Pathol. 2018 Nov;42(11):1556-61.
  11. Mannan AASR, Vieth M, Khararjian A, Khandakar B, Lam-Himlin D, Heydt D, Bhaijee F, Venbrux HJ, Byrnes K, Voltaggio L, Barker N, Yuan S, Montgomery EA. The outlet patch: gastric heterotopia of the colorectum and anus. Histopathology 2018 Aug;73(2):220-9.
  12. Montgomery EA. Diagnostic histochemistry of soft tissue lesions. Semin Diagn Pathol. 2018 Nov;35(6):399-406.
  13. Montgomery E, Arnold CA, Lam-Himlin D, Salimian K, Waters K. Some observations on Barrett esophagus and associated dysplasia. Ann Diagn Pathol 2018 Dec;37:75-82
  14. Noë M, Rezaee N, Asrani K, Skaro M, Groot VP, Wu PH, Olson MT, Hong SM, Kim SJ, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Wirtz D, Roberts NJ, Offerhaus GJA, Brosens LAA, Wood LD, Hruban RH. Immunolabeling of cleared human pancreata provides insights into three-dimensional pancreatic anatomy and pathology. Am J Pathol. 2018 Jul;188(7):1530-5.
  15. Pezhouh MK, Miller JA, Sharma R, Borzik D, Eze O, Waters K, Westerhoff MA, Parian AM, Lazarev MG, Voltaggio L. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization. Hum Pathol. 2018 Dec;82:187-92.
  16. Salimian KJ, Waters KM, Eze O, Pezhouh MK, Tarabishy Y, Shin EJ, Canto MI, Voltaggio L, Montgomery EA. Definition of Barrett Esophagus in the United States: Support for Retention of a Requirement for Goblet Cells. Am J Surg Pathol. 2018 Feb;42(2):264-8.
  17. Suenaga M, Yu J, Shindo K, Tamura K, Almario JAN, Zaykoski CM, Witmer PD, Fesharakizadeh S, Borges M, Lennon AM, Shin EJ, Canto MI, Goggins MG. Pancreatic juice mutation concentrations can help predict the grade of dysplasia in patients undergoing pancreatic surveillance. Clin Cancer Res. 2018 Jun 15;24(12):2963-74.
  18. Tamura K, Yu J, Hata T, Suenaga M, Shindo K, Abe T, MacGregor-Das A, Borges M, Wolfgang CL, Weiss MJ, He J, Canto MI, Petersen GM, Gallinger S, Syngal S, Brand RE, Rustgi A, Olson SH, Stoffel E, Cote ML, Zogopoulos G, Potash JB, Goes FS, McCombie RW, Zandi PP, Pirooznia M, Kramer M, Parla J, Eshleman JR, Roberts NJ, Hruban RH, Klein AP, Goggins M. Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 2018 May;115(18):4767-72.
  19. Waters KM, Salimian KJ, Voltaggio L, Montgomery EA. Refined Criteria for Separating Low-grade Dysplasia and Nondysplastic Barrett Esophagus Reduce Equivocal Diagnoses and Improve Prediction of Patient Outcome: A 10-Year Review. Am J Surg Pathol 2018 Dec;42(12):1723-9.

GENITOURINARY PATHOLOGY

  1. Alharbi AM, De Marzo AM, Hicks JL, Lotan TL, Epstein JI. Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases. Am J Surg Pathol 2018 Oct;42(10):1286-96.
  2. Baena-Del Valle JA, Zheng Q, Esopi DM, Rubenstein M, Hubbard GK, Moncaliano MC, Hruszkewycz A, Vaghasia A, Yegnasubramanian S, Wheelan SJ, Meeker AK, Heaphy CM, Graham MK, De Marzo AM. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. J Pathol 2018 Jan;244(1):11-24.
  3. Bagnasco SM. Beyond the microscope, interpreting renal biopsy findings in the era of precision medicine. Am J Physiol Renal Physiol. 2018 Dec;315(6):F1652-5.
  4. Brosnan-Cashman JA, Yuan M, Graham MK, Rizzo AJ, Myers KM, Davis C, Zhang R, Esopi DM, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. PLoS One. 2018 Sep 18;13(9):e0204159. eCollection 2018.
  5. Chen S, Patil PA, Lepe M, Lombardo KA, Amin A, Matoso A. Retrospective Analysis of Atypical Glands Suspicious for Carcinoma in Transurethral Resection of Prostate. Appl Immunohistochem Mol Morphol. 2018 Mar;26(3):186-91.
  6. Clemmensen T*, Matoso A*, Graham T, Lai WS, Rais-Bahrami S, Gordetsky J. Pathologic and clinical characteristics of early onset renal cell carcinoma. Hum Pathol 2018 Apr;74:25-31. *Co-first author.
  7. Diplas BH, He X, Brosnan-Cashman JA, Liu H, Chen LH, Wang Z, Moure CJ, Killela PJ, Loriaux DB, Lipp ES, Greer PK, Yang R,, Rizzo AJ, Rodriguez FJ, Friedman AH, Friedman HS, Wang S, He Y, McLendon RE, Bigner DD, Jiao Y, Waitkus MS, Meeker AK*, Yan H*. The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma. Nature Communications 2018 May;9(1):2087. (co-senior authorship).
  8. Epstein JI. Prostate cancer grading: A decade after the 2005 modified system. Mod Pathol 2018 Jan;31:S47-63.
  9. Gorski A, Jonczyk-Matysiak E, Kusiak-Szelachowska K, Miedzybrodzki R, Weber-Dabrowska B, Borysowski J, Lekiewicz S, Baginsaka N, Sfanos KS. Phage Therapy in Prostatitis: Recent Prospects. (mini review) Front Microbiol 2018 June;9:Article 1434 (published online)
  10. Haffner MC, Guner G, Taheri D, Netto GJ, Palsgrove DN, Zheng Q, Guedes LB, Kim K, Tsai H, Esopi DM, Lotan TL, Sharma R, Meeker AK, Chinnaiyan AM, Nelson WG, Yegnasubramanian S, Luo J, Mehra R, Antonarakis ES, Drake CG, De Marzo AM. Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer. Am J Pathol. 2018 Jun;188(6):1478-85.
  11. Haffner MC, Taheri D, Luidy-Imada E, Palsgrove DN, Eich ML, Netto GJ, Matoso A, Nirschl TR, Zheng Q, Hicks JL, Nelson WG, De Marzo AM, Marchionni L, Drake CG, Yegnasubramanian S. Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci USA. 2018 Sep ;115(37):E8580-2.
  12. Hassan O, Epstein JI. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT). Am J Surg Pathol 2018 Aug;42(8):1113-20.
  13. Hassan O, Han M, Zhou A, Paulk A, Sun Y, Al-Harbi A, Alraijal A, Baptista Dos Santos F, Epstein JI. Incidence of extra-prostatic extension at radical prostatectomy with pure Gleason score 3+3=6 (Grade Group 1) cancer: Implications for whether Gleason score 6 prostate cancer should be renamed as "not cancer" and for selection criteria for active surveillance. J Urol 2018 Jun;199(6):1482-7.
  14. Hassan O, Matoso A. Clinical significance of subtypes of Gleason pattern 4 prostate cancer. Transl Androl Urol 2018 Sep;7(Suppl 4):S477-S83 (Review).
  15. Hui Y, Lombardo KA, Quddus MR, Matoso A. Cell Polarity Reversal Distinguishes True Micropapillary Growth From Retraction Artifact in Invasive Urothelial Carcinoma. Appl Immunohistochem Mol Morphol 2018 Jan;26(1):e1-e6.
  16. Jamaspishvili T, Berman DM, Ross AE, Scher HI, De Marzo AM, Squire JA, Lotan TL. Clinical Implications of Loss of the PTEN Tumor Suppressor Gene in Prostate Cancer. Nat Rev Urol. 2018 Apr;15(4):222-34. (Review)
  17. Kang H, Antonarakis ES, Luo J, Zheng Q, Rooper L, De Marzo AM, Westra WH, Lotan TL. Detection of AR-V7 transcript with RNA in situ hybridization in human salivary duct cancer. Oral Oncol 2018 Sep;84:134-6.
  18. Kaur HB, Guedes LB, Lu J, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tosoian JJ, Tomlins SA, Schaeffer EM, Joshu CE, Sfanos KS, Lotan TL. Association of Tumor Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate Cancer. Mod Pathol 2018 Oct;31(10):1539-52.
  19. Matoso A, Khandakar B, Yuan S, Wu T, Wang LJ, Lombardo KA, Mangray S, Mannan AASR, Yakirevich E. Spectrum of Findings in Orchiectomy Specimens of Persons Undergoing Gender Confirmation Surgery. Hum Pathol. 2018 Jun;76:91-9.
  20. Maughan BL, Guedes LB, Boucher K, Rajoria G, Liu Z, Klimek S, Zoino R, Antonarakis ES, Lotan TL. p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):260-8.
  21. Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant. 2018 Feb 1;33(2):310-8.
  22. Paluru S, Ulbright TM, Amin M, Montironi R, Epstein JI. The Morphologic Spectrum of Sertoliform Cystadenoma of the Rete Testis: A Series of 15 Cases. Am J Surg Pathol. 2018 Feb;42(2):141-9.
  23. Pan CC, Tsuzuki T, Morii E, Fushimi H, Chen PC, Epstein J. Whole-exome sequencing demonstrates recurrent somatic copy number alterations and sporadic mutations in specialized stromal tumors of the prostate. Hum Pathol. 2018 Jun;76:9-16.
  24. Patel H, Gupta M, Tosoian, JJ, Carter HB, Partin AW, Epstein JI. Subtyping the risk of intermediate-risk prostate cancer for active surveillance based on adverse pathology at radical prostatectomy. J Urol. 2018 Nov;200(5):1068-74.
  25. Patel HD, Tosoian JJ, Carter HC, Epstein JI. Adverse pathologic findings at radical prostatectomy: Is there a favorable intermediate-risk group? JAMA Oncology 2018 Jan 4:89-92.
  26. Porter CM, Shrestha E, Peiffer LB, Sfanos KS. The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis. 2018 Sep;21(3):345-54.
  27. Priore SF, Schwartz LE, Epstein JI. An expanded immunohistochemical profile of osteoclast-rich undifferentiated carcinoma of the urinary tract. Mod Pathol. 2018 Jun;31(6):984-8.
  28. Paulk A, Giannico G, Epstein JI. PIN-like (Ductal) Adenocarcinoma of the Prostate. Am J Surg Pathol 2018 Dec;42(12):1693-1700.
  29. Rosenberg AZ, Wright C, Fox-Talbot K, Rajpurohit A, Williams C, Porter C, Kovbasnjuk O, McCall MN, Shin JH, Halushka MK. xMD-miRNA-seq to generate near in vivo miRNA expression estimates in colon epithelial cells. Sci Rep. 2018 Jun 28;8(1):9783.
  30. Samaan S, Quddus MR, Matoso A. "Man in Istanbul" Lesions of the Urinary Tract (Known Entities in an Unusual Context): Melanoma, Carcinoid Tumors, Epithelioid Angiosarcoma. Surg Pathol Clin. 2018 Dec;11(4):825-36. Review.
  31. Sfanos KS, Markowski MC, Peiffer LB, Ernst SE, White JR, Pienta KJ, Antonarakis ES, Ross AE. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis. 2018 July;21:539-48. (published online)
  32. Sfanos KS, Yegnasubramanian S, Nelson WG, DeMarzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2018 Jan;15(1):11-24.
  33. Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM, Yegnasubramanian S, Mangold LA, Partin AW, Sfanos KS. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer. J Urol. 2018 Jan;199(1):161-71.
  34. Sun Y, Argani P, Tickoo SK, Epstein JI. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts. Am J Surg Pathol. 2018 Oct;42(10):1396-1401.
  35. Torres A, Alshalalfa M, Davicioni E, Gupta A, Yegnasubramanian S, Wheelan SJ, Epstein JI, De Marzo AM, Lotan TL. ETS2 is a Prostate Basal Cell Marker and is Highly Expressed in Prostate Cancers Aberrantly Expressing p63. Prostate. 2018 Sep;78(12):896-904.
  36. Tosoian JJ, Alam R, Ball MW, Carter HB, Epstein JI. Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy. Nat Rev Urol. 2018 Jan;15(1):55-66.
  37. Tregnago AC, Epstein JI. Skene's Glands Adenocarcinoma: A Series of 4 Cases. Am J Surg Pathol. 2018 Nov;42(11):1513-21.
  38. Yang Z, Epstein JI. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases. Am J Surg Pathol 2018 Jul;42(7):971-6.

GYNECOLOGIC PATHOLOGY

  1. Cheng MA, Farmer E, Huang C, Lin J, Hung CF, Wu TC. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases. Hum Gene Ther 2018 Sep;29(9):971-96. (review)
  2. Chuang YM, Pinn ML, Karakousis PC, Hung CF. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice. Front Cell Infect Microbiol. 2018 Feb 8;8:31. eCollection 2018.
  3. Kim YS, Park HJ, Park JH, Hong EJ, Jang GY, Jung ID, Han HD, Lee SH, Vo MC, Lee JJ, Yang A, Farmer E, Wu TC*, Kang TH*, Park YM*. A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells. OncoImmunology. 15 Aug 2018. DOI: 10.1080/2162402X.2018.1472187 (*co-corresponding author)
  4. Lin YH, Yang MC, Tseng SH, Jiang R, Yang A, Farmer E, Peng S, Henkle T, Chang YN, Hung CF, Wu T-C. Integration of oncogenes via Sleeping Beauty as a mouse model of HPV16+ Oral tumor and immunologic control. Cancer Immunol Res 2018 Mar;6(3):305-19.
  5. Mao CP, Peng S, Yang A, He L, Tsai YC, Hung CF, Wu TC. Programmed self-assembly of peptide-major histocompatibility complex for antigen-specific immune modulation. Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4032-40.
  6. Murdock T, Ronnett BM, Rodriguez GJ. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis : Clinicopathologic Analysis of 23 Cases. Am J Surg Pathol 2018 Nov;42(11):1429-44.
  7. Pisanic TR 2nd, Cope LM, Lin SF, Yen TT, Athamanolap P, Asaka R, Nakayama K, Fader AN, Wang TH, Shih IM, Wang TL. Methylomic analysis of ovarian cancers identifies tumor-specific alterations readily detectable in early precursor lesions. Clin Cancer Res 2018 Dec;24(24):6536-47.
  8. Qiu J, Peng S, Ma Y, Yang A, Farmer E, Cheng MA, Roden RBS, Wu TC, Chang YN, Hung CF. Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination. Virology 2018 Dec;525:205-15.
  9. Roden RBS, Stern PL. Opportunities and challenges for human papillomavirus vaccination in cancer. Nat Rev Cancer. 2018 Apr;18(4):240-54.
  10. Ronnett BM. Hydatidiform moles: ancillary techniques to refine diagnosis. Arch Pathol Lab Med 2018 Dec;142(12):1485-502.
  11. Song KH, Kim JH, Lee YH, Bae HC, Lee HJ, Woo SR, Oh SJ, Lee KM, Yee C, Kim BW, Cho H, Chung EJ, Chung JY, Hewitt SM, Chung TW, Ha KT, Bae YK, Mao CP, Yang A, Wu TC*, Kim TW*. Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance. J Clin Invest. 2018 Aug 31;128(9) 4098-144. (*co-corresponding author)
  12. Wang JW, Wu WH, Huang TC, Wong M, Kwak K, Ozato K, Hung CF, Roden RBS. Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus. J Virol 2018 Jul;92(15). pii: e00572-18. doi: 10.1128/JVI.00572-18.
  13. Xing D, Banet N, Sharma R, Vang R, Ronnett BM, Illei PB. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study. Hum Pathol. 2018 Feb;72:160-6.
  14. Xing D, Jenson EG, Zwick CA, Rodriguez FJ, Kurman RJ. Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report. Int J Gynecol Pathol. 2018 Jan;37(1):52-6.
  15. Xing D, Zheng G, Schoolmeester JK, Li Z, Pallavajjala A, Haley L, Conner MG, Vang R, Hung CF, Wu TC, Ronnett BM. Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix. Am J Surg Pathol 2018 Jun;42(6):750-60.
  16. Yang JM, Bhattacharya S, West-Foyle H, Hung CH, Wu TC, Iglesias PA, Huang CH. Integrating chemical and mechanical signals through dynamic coupling between cellular protrusions and pulsed ERK activation. Nat Commun. 2018 Nov 07; 9(1):article #4673
  17. Yu Y, Suryo Rahmanto Y, Lee MH, Wu PH, Phillip JM, Huang CH, Vitolo MI, Gaillard S, Martin SS, Wirtz D, Shih IM, Wang TL. Inhibition of ovarian tumour cell invasiveness by targeting SYK in tyrosine kinase signaling pathway. Oncogene. 2018 Jul;37(28):3778-89.

HEMATOLOGIC PATHOLOGY

  1. Dezern AE, Borowitz MJ. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility. Cytometry B Clin Cytom. 2018 Jan;94(1):16-22.
  2. Duffield AS, Borowitz MJ. Syphilitic lymphadenitis with abscess formation involving cervical lymph nodes. Blood. 2018 Feb 8;131(6):707.
  3. Zheng G, Streiff MB, Takemoto CM, Bynum J, Gelwan E, Jani J, Kickler TS. The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia. Clin Appl Thromb Hemost 2018 Jul;24(5):749-54.

IMMUNOLOGY

  1. Ahmed R, Omidian Z1, Donner T, Hamad ARA. Hiding in Plain Sight: Time to Unlock Autoimmune Clues in Human CD5+ B Cells by Using NextGen Technology. Discov Med. 2018 Sep;26(142):79-83.
  2. Amukele TK, Jones R, Elbireer A. Test Cost and Test Accuracy in Clinical Laboratories in Kampala, Uganda. Am J Clin Pathol 2018 Apr;00:1-7.
  3. Amukele TK, Riley S, Tesfazghi MT. Voices from the Field: Interviews with Global Health Pathology Volunteers. Clinics in Laboratory Medicine 2018 Mar;38(1):11-20.
  4. Chalan P, Di Dalmazi G, Pani F, De Remigis A, Corsello A, Caturegli P. Thyroid dysfunctions secondary to cancer immunotherapy. J Endocrinol Invest. 2018 Jun;41(6):625-38.
  5. Chen G, Bracamonte-Baran W, Diny NL, Hou X, Talor MV, Fu K, Liu Y, Davogustto G, Vasquez H, Taegtmeyer H, Frazier OH, Waisman A, Conway SJ, Wan F, Čiháková D. Sca-1+ cardiac fibroblasts promote development of heart failure. Eur J Immunol. 2018 Sep;48(9):1522-38.
  6. Čiháková D. Interleukin-10 stiffens the heart. J Experimental Med. 2018;215(2):379-81.
  7. Čiháková D, Eaton WW, Talor MV, Harkus UH, Demyanovich HK, Rodriguez K, Feldman S, Kelly DL. Gliadin-related antibodies in schizophrenia (letter to editor). Schizophr Res. 2018 May;195:585-6.
  8. Detrick B, Gangaputra S, Palsgrove DN, Heaney CD, Hooks JJ, Nida Sen H. Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients. J Neuroimmunol. 2018 Mar;316:74-79.
  9. Diny NL, Baldeviano GC, Talor MV, Barin JG, Ong S, Bedja D, Hays AG, Gilotra NA, Coppens I, Rose NR, Čiháková D. Eosinophil-derived IL-4 drives inflammatory dilated cardiomyopathy. J Exp Med. 2017 Apr;214(4):943-57.
  10. Giraldo NA, Nguyen P, Engle EL, Kaunitz GJ, Cottrell TR, Berry S, Green B, Soni A, Cuda JD, Stein JE, Sunshine JC, Succaria F, Xu H, Ogurtsova A, Danilova L, Church CD, Miller NJ, Fling S, Lundgren L, Ramchurren N, Yearley JH, Lipson EJ, Cheever M, Anders RA, Nghiem PT, Topalian SL, Taube JM. Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab. J Immunother Cancer. 2018 Oct 1;6(1):99.
  11. Hickey JW, Isser AY, Vicente FP, Warner SB, Mao HQ, Schneck JP. Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties. Biomaterials 2018 Dec;187:105-16.
  12. Hickey JW, Schneck JP. Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles. J Vis Exp 2018 Nov;(141). doi: 10.3791/58640
  13. Jaiswal AK, Sadasivam M, Archer NK, Miller RJ, Dillen CA, Ravipati A, Park PW, Chakravarti S, Miller LS, Hamad ARA. Syndecan-1 Regulates Psoriasiform Dermatitis by Controlling Homeostasis of IL-17-Producing γδ T Cells. J Immunol 2018 Sep 15;201(6):1651-61.
  14. Jaiswal AK, Sadasivam M, Hamad ARA. Unexpected alliance between syndecan-1 and innate-like T cells to protect host from autoimmune effects of interleukin-17. World J Diabetes 2018 Dec 15;9(12):220-5.
  15. Kosmides AK, Necochea K, Hickey JW, Schneck JP. Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation. Nano Lett. 2018 Mar 14;18(3):1916-24.
  16. Lee SA, Noel S, Sadasivam M, Allaf ME, Pierorazio PM, Hamad ARA*, Rabb H*. Characterization of kidney CD45intCD11bintF4/80+ MHCII+ CX3CR1+ Ly6C-"intermediate mononuclear phagocytic cells". PloS one 2018 June;13(6):e0198608 (co-senior authorship).
  17. Mohan D, Wansley DL, Sie BM, Noon MS, Baer AN, Laserson U, Larman HB. PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes. Nat Protoc 2018 Sep;13(9):1958-78.
  18. Schroeder LF, Guarner J, Amukele TK. Essential Diagnostics for the Use of World Health Organization Essential Medicines. Clin Chem. 2018 Aug;64(8):1148-57.
  19. Sidhom JW, Bessell CA, Havel JJ, Kosmides A, Chan TA, Schneck JP. ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis. Cancer Immunol Res 2018 Feb;2:151-62.

INFORMATICS

  1. Kwon R, Allen LA, Scherer LD, Thompson JS, Abdel-Maksoud MF, McIlvennan CK, Matlock DD. The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey. Medical Decision Making July;38(5):584-92.
  2. Lai S, Heaphy CM, Rizzo AJ, Celentano DD, Gerstenblith G, Li J, Moore RD, Treisman G, Chen S, Foster P, Kickler T, Lai H. Cocaine use may induce telomere shortening in individuals with HIV infection. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun;84(Pt A):11-7.
  3. Li J, Lai H, Chen S, Lai S. Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults. Int J STD AIDS 2018 Jul;29(8):781-9.

MEDICAL MICROBIOLOGY

  1. Fowler MG, Flynn P, Aizire J. What is new in perinatal HIV prevention? Curr Opin Pediatr. 2018 Feb;30(1):144-51.
  2. Martin IW, Dionne K, Deml SM, Wengenack NL, Parrish NM. Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation. Diagn Microbiol Infect Dis. 2018 May;91(1):38-41.
  3. Namale-Matovu J, Owora AH,, Onyango-Makumbi C, Mubiru M1, Namuli PE, Motevalli-Oliner M, Musoke P, Nolan M, Fowler MG. Comparative effects of three methods of promoting breastfeeding among human immunodeficiency virus-infected women in Uganda: a parallel randomized clinical trial. Int Health. 2018 Nov 1;10(6):430-41.
  4. Pancholi P*, Carroll KC*, Buchan BW, Chan RC, Dhirman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledoboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM*. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis. J Clin Microbiol. 2018 Apr;26;56(4):e01329-17.
  5. Rock C, Anderson M, Lewis S, Scheeler V, Nowakowski E, Hsu YJ, Milstone AM, Carroll KC, Maragakis LL, Simner PJ; CDC Prevention Epicenters Program. Comparison of nylon-flocked swab and cellulose sponge methods for carbapenem-resistant Enterobacteriaceae and gram-negative organism recovery from high-touch surfaces in patient rooms. Infect Control Hosp Epidemiol. 2018 Oct;39(10):1257-61.
  6. Schwartz M, Fisher S, Story-Roller E, Lamichhane G, Parrish N. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis. Microb Drug Resist 2018 Oct;24(8):1191-7.
  7. Simner PJ, Antar AAR, Hao S, Gurtowski J, Tamma PD, Rock C, Opene BNA, Tekle T, Carroll KC, Schatz MC, Timp W. Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae. J Antimicrob Chemother. 2018 Jul;73(7):1796-803.
  8. Simner PJ, Goodman KE, Carroll KC, Harris AD, Han JH, Tamma PD. Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms. Open Forum Infect Dis. 2018 May 17;5(5):ofy094. doi: 10.1093/ofid/ofy094. eCollection 2018 May.
  9. Simner PJ, Miller S, Carroll KC. Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases. Clin Infect Dis. 2018 Feb 10;66(5):778-88.
  10. Simner PJ, Miller HB, Breitwieser FP, Pinilla Monsalve G, Pardo CA, Salzberg SL, Sears CL, Thomas DL, Eberhart CG, Carroll KC. Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebrospinal Fluid Diagnostics. J Clin Microbiol. 2018 Aug 27;56(9). pii: e00472-18. doi: 10.1128/JCM.00472-18. Print 2018 Sep.
  11. Taha TE, Yende-Zuma N, Aizire J, Chipato T, Wambuzi Ogwang L4 Makanani B, Chinula L, Nyati MM, Hanley S, Brummel SS, Fowler MG. The multi-country PROMOTE HIV antiretroviral treatment observational cohort in Sub-Saharan Africa: Objectives, design, and baseline findings. PLoS One. 2018 Dec 13;13(12):e0208805
  12. Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC4, Hsu AJ, Timp W, Simner PJ. Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam. Antimicrob Agents Chemother. 2018 Apr;27;62(4).
  13. Tamma PD, Simner PJ. Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates. J Clin Microbiol. 2018 Nov;56(11):e01140-18.
  14. Yao JD, Young S, Heilek GM, Marino E, Paxinos EE, Marins EG, Valsamakis A. Diagnosis and monitoring of HCV infection using the cobas® HCV test for use on the cobas® 6800/8800 systems. J Clin Virol. 2018 May;102:63-69.

MOLECULAR PATHOLOGY

  1. Debeljak M, Noë M, Riel SL, Haley LM, Norris AL, Anderson DA, Adams EM, Suenaga M, Beierl KF, Lin MT, Goggins MG, Gocke CD, Eshleman JR. Validation Strategy for Ultrasensitive Mutation Detection. Mol Diagn Ther. 2018 Oct;22(5):603-11.
  2. Gocke CD, Gladstone DE. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. Br J Haematol. 2018 Jan;180(1):33-40.
  3. Nguyen D, Haley L, Pallavajjala A, Gojo I, Ning Y. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia. Leuk Lymphoma. 2018 Jan;59(1):265-7. (Letter to Editor)
  4. Pallavajjala A, Kim D, Li T, Ghiaur G, Jones RJ, Burns KH, Salzberg SL, Ning Y. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia. Leuk Lymphoma. 2018 May;59(5):1231-8.
  5. Walker A, Singh A, Tully E, Woo J, Le A, Nguyen T, Biswal S, Sharma D, Gabrielson E. Nrf2 signaling and autophagy are complementary in protecting breast cancer cells during glucose deprivation. Free Radic Biol Med 2018 May 20;120:407-13.
  6. Ware AD, Birkness J, Duffield AS, Gocke CD. Molecular evidence of JAK2 p.V617F mutated pure erythroid leukemia arising from polycythemia vera. Virchows Arch 2018 Jul;473(1):131-5.

NEUROPATHOLOGY

  1. Ames HM, Rooper LM, Laterra JJ, Eberhart CG, Rodriguez FJ. INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma. J Neuropathol Exp Neurol. 2018 May 1;77(5):374-82.
  2. Chen W, Wang S, Mestre AA, Fu C, Makarem A, Xian F, Hayes LR, Lopez-Gonzalez R, Drenner K, Jiang J, Cleveland DW, Sun S. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2ÎÄ… phosphorylation. Nat Communications2018 Jan;9;Article number 51 - Open Access.
  3. Nie S, Tan T, Zhang Z, Chen G, Xiong J, Hu D, Ye K, Zhang Y, Cao Y, Zhang ZH, Chen L. Bilateral Implantation of Shear Stress Modifier in ApoE Knockout Mouse Induces Cognitive Impairment and Tau Abnormalities. Front Aging Neurosci. 2018 Oct 4;10:303.
  4. Kageyama Y, Saito A, Pletnikova O, Rudow GL, Irie Y, An Y, Murakami K, Irie K, Resnick SM, Fowler DR, Martin LJ, Troncoso JC. Amyloid ÎË› toxic conformer has dynamic localization in the human inferior parietal cortex before amyloid β plaques form. Sci Rep. 2018 Nov 15;8(1):16895.
  5. Knight AC, Brill SA, Queen SE, Tarwater PM, Mankowski JL. Increased Microglial CSF1R Expression in the SIV/Macaque Model of HIV CNS Disease. J Neuropathol Exp Neurol. 2018 Mar;77(3):199-206.
  6. Martin LJ, Chang Q. DNA damage response and repair, DNA methylation, and cell death in human neurons and experimental animal neurons are different. J Neuropathol Exp Neurol. 2018 Jul 1;77(7):636-55.
  7. Nix JS, Haffner MC, Ahsan S, Hicks J, De Marzo AM, Blakeley J, Raabe EH, Rodriguez FJ. Malignant Peripheral Nerve Sheath Tumors Show Decreased Global DNA Methylation. J Neuropathol Exp Neurol 2018 Oct 1;77(10):958-63.
  8. Palsgrove DN, Brosnan-Cashman JA, Giannini C, Raghunathan A, Jentoft M, Bettegowda C, Gokden M, Lin D, Yuan M, Lin MT, Heaphy CM, Rodriguez FJ. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association. Mod Pathol 2018 Dec;31(12):1787-800.
  9. Pletnikova O, Kageyama Y, Rudow G, LaClair KD, Albert M, Crain BJ, Tian J, Fowler D, Troncoso JC. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype. Neurobiol Aging. 2018 Jul 19;71:72-80.
  10. Raghavan A, Wilson A, Wend C, Alexander A, Habela C, Nauen D. Open-source system for millisecond-synchronized continuous video-EEG. Epilepsy Res 2018 Sep;145:27-30.
  11. Yuan M, Da Silva ACAL, Arnold A, Okeke L, Ames H, Correa-Cerro LS, Vizcaino MA, Ho CY, Eberhart CG, Rodriguez FJ. MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. Scientific Reports 2018 Aug;8:Article number: 12506 (open access)
  12. Ziogas NK, Koliatsos VE. Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods. J Neurosci 2018 Apr;38(16):4031-47.

OPHTHALMIC PATHOLOGY

  1. Asnaghi L, White DT, Key N, Choi J, Mahale A, Alkatan H, Edward DP, Elkhamary SM, Al-Mesfer S, Maktabi A, Hurtado CG, Lee GY, Carcaboso AM, Mumm JS, Safieh LA, Eberhart CG. ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma. Oncogene. 2018 Nov 6. doi: 10.1038/s41388-018-0543-2.
  2. Li G, Adams E, Eshleman JR, Eberhart CG. No BRAF V600E Mutation Identified in 28 Periocular Pyogenic Granuloma. Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):525-7.
  3. Li Z, Breitwieser FP, Lu J, Jun AS, Asnaghi L, Salzberg SL, Eberhart CG. Identifying Corneal Infections in Formalin-Fixed Specimens Using Next Generation Sequencing. Invest Ophthalmol Vis Sci 2018 Jan;59(1):280-8.
  4. Tso MOM, Suarez MJ, Eberhart CG. Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization. Am J Ophthalm Case Reps 2018 Sep;11:176-80.
  5. Vizcaino MA, Joseph SS, Eberhart CG. Orbital progressive transformation of germinal centers as part of the spectrum of IgG4-related ophthalmic disease: Clinicopathologic features of three cases. Saudi J Ophthalmol 2018 Jan-Mar;32(1):56-61.

SURGICAL PATHOLOGY

  1. Argani P. A Molecular Marker for Eosinophilic Solid and Cystic Renal Cell Carcinoma. Eur Urol. 2018 Oct;74(4):487-8.
  2. Argani P, Pawel B, Szabo S, Reyes-Múgica M, Timmons C, Antonescu CR. Diffuse Strong BCOR Immunoreactivity Is a Sensitive and Specific Marker for Clear Cell Sarcoma of the Kidney (CCSK) in Pediatric Renal Neoplasia. Am J Surg Pathol 2018 Aug;42(8):1128-31. Letter to Editor
  3. Argani P, Reuter VE, Kapur P, Brown JE, Sung YS, Zhang L, Williamson R, Francis G, Sommerville S, Swanson D, Dickson BC, Antonescu CR. Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney. Am J Surg Pathol. 2018 Nov;42(11):1562-70.
  4. Baras AS, Naidoo J, Hann CL, Illei PB, Reninger CW 3rd, Lauring J. Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling. J Natl Compr Canc Netw. 2018 May;16(5):467-72.
  5. Birkbak NJ, Li Y, Pathania S, Greene-Colozzi, Dreze M, Bowman-Colin C, Sztupinszki Z, Krzystanek M, Diossy M, Tung N, Ryan PD, Garber JE, Silver DP, Iglehart JD, Wang ZC, Szuts D, Szallasi Z, Richardson AL. Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple negative breast and serous ovarian cancers. Ann Oncol. 2018 Apr 1;29(4):903-9.
  6. Blakely AM*, Matoso A*, Patil PA, Taliano R, Machan JT, Miner TJ, Lombardo KA, Resnick MB, Wang LJ. Role of Immune Microenvironment in Gastrointestinal Stromal Tumors. Histopathology 2018 Feb;72(3):405-13. (co-first author)
  7. Chang L, Zhang L, Xu J, Meyers CA, Li Z, Yan N, Zou E, James AW. Lineage-Specific Wnt Reporter Elucidates Mesenchymal Wnt Signaling during Bone Repair. Am J Pathol 2018 Oct;188(10):2155-63. (short communication)
  8. Cimino-Mathews A. Axillary Lymph Node Inclusions. Surg Pathol Clinics 2018 Mar;11(1):43-59.
  9. Cloutier J, Thompson ED, Cimino-Mathews A, Rooper LM, Matoso A, Argani P. Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs. Hum Pathol 2018 Dec;82:76-86.
  10. Cocks M, Helmke E, Meyers CA, Fayad L, McCarthy E, James AW. Bizarre parosteal osteochondromatous proliferation: 16 cases with a focus on histologic variability. J Orthopaedics, Jan 2018;15(1):138-42.
  11. Cottrell TR, Thompson ED, Cimino-Mathews A, Taube JM. Pathologic Features of Response to Neoadjuvant Anti-PD-1 in Resected Non-Small Cell Lung Carcinoma: A Proposal for Quantitative Immune-Related Pathologic Response Criteria (irPRC). Ann Oncol. 2018 Aug;29(8):1853-60.
  12. Khararjian A, Mathew P, Choudhary A, Baras A. Cost Effectiveness of Intraoperative Gross Examination in Colorectal Resections: A Retrospective Review of 200 Consecutive Cases. Arch Pathol Lab Med. 2018 Nov;142(11):1403-6.
  13. Li Y, Reuter VE, Matoso A, Netto GJ, Epstein JI, Argani P. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients. Histopathology. 2018 Mar;72(4):588-600.
  14. McCuiston A, Bishop JA. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors. Head Neck Pathol. 2018 Mar;12(1):89-94.
  15. Meyer CA, Xu J, Asatrian G, Ding C, Shen J, Broderick K, Ting K, Soo C, Peault B, James AW. WISP-1 drives bone formation at the expense of fat formation in human perivascular stem cells. Scientific Reports volume 8, Article number: 15618 published online October 23, 2018.
  16. Meyers CA, Shen J, Lu A, James AW. WNT16 induces proliferation and osteogenic differentiation of human perivascular stem cells. J Orthop 2018 Aug 16;15(3):854-7.
  17. Meyers CA, Xu J, Zhang L, Asatrian G, Ding C, Yan N, Broderick K, Sacks J, Goyal R, Zhang X, Ting K, Péault B, Soo C, James AW. Early Immunomodulatory Effects of Implanted Human Perivascular Stromal Cells During Bone Formation. Tissue Eng Part A. 2018 Mar;24(5-6):448-57.
  18. Palsgrove DN, Li Y, Pratilas CA, Lin MT, Pallavajjalla A, Gocke C, De Marzo AM, Matoso A, Netto GJ, Epstein JI, Argani P. Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum. Am J Surg Pathol. 2018 Sep;42(9):1166-81.
  19. Patil PA, Blakely AM, Lombardo KA, Machan JT, Miner TJ, Wang LJ, Marwaha AS, Matoso A. Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma. Histopathology 2018 Jul;73(1):124-36.
  20. Rooper LM, Bishop JA, Westra WH. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors. Am J Surg Pathol. 2018 May;42(5):665-71.
  21. Shen J, Chen X, Jia H, Meyers CA, Shrestha S, Asatrian G, Ding C, Tsuei R, Zhang X, Peault B, Ting K, Soo C, James AW. Effects of WNT3A and WNT16 on the osteogenic and adipogenic differentiation of perivascular stem cells. Tissue Eng Part A. Jan 2018; 24(1-2):68-80.
  22. Taube JM, Galon J, Sholl LM, Rodig SJ, Cottrell TR, Giraldo NA, Baras AS, Patel SS, Anders RA, Rimm DL, Cimino-Mathews A. Implications of the tumor immune microenvironment for staging and therapeutics. Mod Pathol. 2018 Feb;31(2):214-34.
  23. Zhang L, Chang L, Xu J, Meyers CA, Yan N, Zou E, James AW. Lineage specific Wnt reporter elucidates mesenchymal Wnt signaling during bone repair. Am J Pathol. 2018 Oct;188(10):2155-63.
  24. Zhang L, Chang L, Xu J, Meyers CA, Yan N, Zou E, Ding C, Ting K, Soo C, Pang S, James AW. Frontal Bone Healing Is Sensitive to Wnt Signaling Inhibition via Lentiviral-Encoded Beta-Catenin Short Hairpin RNA. Tissue Eng Part A. 2018 Dec;24(23-24):1742-52.

TRANSFUSION MEDICINE

  1. Bloch EM, Ingram C, Hull J, Fawcus S, Anthony J, Green-Thompson R, Crookes RL, Ngcobo S, V Creel D, Courtney L, Bellairs GRM, Murphy EL; South Africa Program of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Risk factors for peripartum blood transfusion in South Africa: a case-control study. Transfusion. 2018 Sep;58(9):2149-56.
  2. Bloch EM, Kasubi M, Levin A, Mrango Z, Weaver J, Munoz B, West SK Babesia microti and Malaria Infection in Africa: A Pilot Serosurvey in Kilosa District, Tanzania. Am J Trop Med Hyg. 2018 Jul;99(1):51-56.
  3. Bloch EM, Marshall CE, Boyd JS, Shifflett L, Tobian AAR, Gehrie EA, Ness PM. Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions. Transfusion. 2018 Jul;58(7):1647-53.
  4. Bloch EM, Ness PM, Tobian AAR, Sugarman J. Revisiting Blood Safety Practices Given Emerging Data about Zika Virus. N Engl J Med. 2018 May 10;378(19):1837-41.
  5. Bloch EM, Yang Y, He M, Tonnetti L, Liu Y, Wang J, Guo Y, Li H, Leiby DA, Shan H. A pilot serosurvey of Babesia microti in Chinese blood donors. VoxSanguinis 2018 May;113:345-9.
  6. Brissett DI, Tuholske C, Allen IE, Larios NS, Mendoza DJ, Murillo AG, Bloch EM. Zika Virus: Knowledge Assessment of Residents and Health-Care Providers in RoatÁn, Honduras, following an Outbreak. Am J Trop Med Hyg. 2018 Jul;99(1):211-5.
  7. Bynum JP, Zachary A, Ness PM, Luo X, Bagnasco S, King KE, Segev DL, Orandi BJ, Warren DS, Fuller A, Ciappi A, Montgomery R, Tobian AAR. Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts. Transfusion. 2018 Aug;58(8):1951-7.
  8. Dam KH, Kaufman MR, Patel EU, Van Lith LM, Hatzhold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Parental communication, engagement, and support during the adolescent voluntary medical male circumcision experience. Clin Infec Dis 2018 Apr;66:S189-S97.
  9. Erony SM, Marshall CE, Gehrie EA, Boyd JS, Ness PM, Tobian AAR, Carroll KC, Blagg L, Shifflett L, Bloch EM. The epidemiology of bacterial culture-positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016. Transfusion. 2018 Aug;58(8):1933-9.
  10. Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM. Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. J Clin Virol 2018 Feb - Mar;99-100:67-70.
  11. Gehrie EA. Atypical bacterial growth within units of platelets challenges transfusion medicine dogma. J Clin Microbiol. 2018 Nov 27;56(12). pii: e01363-18. doi: 10.1128/JCM.01363-18. Print 2018 Dec.
  12. Gehrie EA, Roubinian NH, Chowdhury D, Brambilla DJ, Murphy EL, Gottschall JL, Wu Y, Ness PM, Strauss RG, Hendrickson JE7; NHLBI Recipient Epidemiology-Donor Evaluation Study (REDS-III). Vox Sang. 2018 Feb;113(2):160-9.
  13. Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, Tobian AAR. Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. JAMA 2018 Feb 27;319(8):825-7. (Letter)
  14. Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, Vasovic LV, Sheth S, Nellis ME, Shaz B, Tobian AAR. Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry. JAMA Surg 2018 Sep 1;153(9):826-33.
  15. Grabowski MK, Herbeck JT, Poon AFY. Genetic Cluster Analysis for HIV Prevention. Curr HIV/AIDS Rep Feb 2018; https://doi.org/10.1007/s11904-018-0384-1 (Open Access):1-8.
  16. Grabowski MK, Reynolds SJ, Kagaayi J, Gray RH, Clarke W, Nakigozi G, Laeyndecker O, Redd AD, Billioux V, Ssekubugu R, Nalugoda F, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR. The validity of self-reported antiretroviral use in persons living with HIV: a population-based study. AIDS 2018 Jan;32(3):363-9.
  17. Kaufman MR, Dam KH, Sharma K, Van Lith LM, Hatzhold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Patel EU, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Females' peer influence and support for adolescent males receiving voluntary medical male circumcision services. Clin Infec Dis 2018 Apr;66: S183-S8.
  18. Kaufman MR, Patel EU, Dam KH, Packman ZR, Van Lith LM, Hatzhold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Impact of counseling received by adolescents undergoing voluntary medical male circumcision on knowledge and sexual intentions. Clin Infect Dis 2018 Apr;66(suppl_3):S221-S8.
  19. Kaufman MR, Patel EU, Dam KH, Packman ZR, Van Lith LM, Hatzhold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Counseling received by adolescents undergoing voluntary medical male circumcision: moving towards age equitable comprehensive human immunodeficiency virus prevention measures. Clinical Infectious Diseases. Clin Infect Dis 2018 Apr;66(suppl_3): S213-20.
  20. Keiser AM, Booth GS, Gehrie E. With a simple calculation, the fraction of platelets remaining can be used to estimate the residual hemoglobin S percentage in sickle cell disease patients undergoing automated red blood cell exchange. Transfus Apher Sci. 2018 Apr;57(2):250-2.
  21. Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. J Int AIDS Soc. 2018 Feb;21(2). (open access).
  22. Lokhandwala PM, O'Neal A, Patel EU, Brunker PAR, Gehrie EA, Zheng G, Kickler TS, Ness PM, Tobian AAR. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Transfusion 2018 May; 58:1126-31.
  23. Lokhandwala PM, Shabihkhani M, Ness PM, Bloch EM. Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor. Transfus Apher Sci. 2018 Apr;57(2):225-7.
  24. Lokhandwala PM, Shike H, Wang M, Domen RE, George MR. Optimizing donor scheduling before recruitment: An effective approach to increasing apheresis platelet collections. PLoS One. 2018 May 30;13(5):e0198062. doi: 10.1371/journal.pone.0198062. eCollection 2018.
  25. Mavhu W, Hatzhold K, Dam KH, Kaufman MR, Patel EU, Van Lith LM, Kahabuka C, Marcell AV, Mahlasela L, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Adolescent wound-care self-efficacy and practices after voluntary medical male circumcision - a multi-country assessment. Clin Infect Dis 2018 Apr;66(suppl_3): S229-S35.
  26. McGonigle AM, Tobian AAR, Zink JL, King KE. Perfect storm: therapeutic plasma exchange for a patient with thyroid storm. J Clin Apher 2018 Feb;33(1):113-16.
  27. Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C, Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S, Eron JJ, Gallant JE, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Pilotto JH, Kumwenda J, Akelo V, Godbole SV, Santos BR, Grinsztejn B, Panchia R, Chariyalertsak S, Makhema J, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH. HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052. J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):484-91.
  28. Patel EU, Gaydos CA, Packman ZR, Quinn TC, Tobian AAR. Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States. Clin Infect Dis 2018 Jul;67(2):211-7.
  29. Patel EU, Grabowski MK, Eisenberg A, Packman ZR, Gravitt PE, Tobian AAR. Increases in in human papillomavirus vaccination among adolescents and young adults in the United States, 2011-2016. J Infect Dis. 2018 Jun 5;218(1):109-13.
  30. Patel EU, Kaufman MR, Dam KH, Van Lith LM, Hatzhold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Age differences in perceptions of and motivations for voluntary medical male circumcision among adolescents in South Africa, Tanzania, and Zimbabwe. Clin Infect Dis 2018 Apr;66(suppl_3): S173-S82.
  31. Sivay MV, Fogel JM, Wang J, Zhang Y, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Hamilton EL, Kahn K, Selin A, Gomez-Olive FX, MacPhail C, Hughes J, Pettifor A, and Eshleman SH. Natural control of HIV infection in young women in South Africa: HPTN 068. HIV Clin Trials. 2018 Oct;19(5):202-8.
  32. Tobian AAR, Hume HA. Quest for the holy grail: pathogen reduction in low-income countries. Transfusion. 2018 Apr;58(4):836-9. (Editorial)
  33. Tobian AAR, Dam KH, Van Lith LM, Hatzold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Patel EU, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Kaufman MR. Providers' perceptions and training needs for counseling adolescents undergoing voluntary medical male circumcision. Clin Infect Dis 2018 Apr;66(suppl_3):S198-204.
  34. Van Lith LM, Mallalieu EC, Patel EU, Dam KH, Kaufman MR, Hatzhold K, Marcell AV, Mavhu W, Kahabuka C, Mahlasela L, Njeuhmeli E, Seifert-Ahanda K, Ncube G, Lija G, Bonnecwe C, Tobian AAR. Perceived quality of in-service communication and counseling among adolescents undergoing voluntary medical male circumcision. Clin Infect Dis 2018 Apr;66(suppl_3): S205-S12.
  35. Vostal JG, Buehler PW, Ness PM. Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016. Transfusion 2018 Jan;58(1):255-66.
  36. Ware AD, Jacquot C, Tobian AAR, Gehrie EA, Ness PM, Bloch EM. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sang. 2018 Jan;113(1):3-12.
  37. Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH. Antiretroviral Drug Use and HIV Drug Resistance Among MSM and Transgender Women in Sub-Saharan Africa. AIDS 2018 Jun;32(10):1301-6.
  38. Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, GÓmez-Olivé FX, Hughes JP, Pettifor A, Eshleman SH. Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068. J Acquir Immune Defic Syndr 2018 Nov 1;79(3):315-22.